Durability of long-lasting insecticidal nets (LLINs) in Ethiopia.

Alpha-cypermethrin Attrition Bio-efficacy Deltamethrin Durability Ethiopia LLIN Malaria Physical-integrity Survival

Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
26 Mar 2023
Historique:
received: 03 02 2023
accepted: 22 03 2023
medline: 28 3 2023
entrez: 26 3 2023
pubmed: 27 3 2023
Statut: epublish

Résumé

The functional survival time of long-lasting insecticidal nets (LLINs), which varies across different field contexts, is critical for the successful prevention of malaria transmission. However, there is limited data on LLIN durability in field settings in Ethiopia. A three-year longitudinal study was conducted to monitor attrition, physical integrity, and bio-efficacy and residual chemical concentration of LLINs in four regions in Ethiopia. World Health Organization (WHO) guidelines were used to determine sample size, measure physical integrity, and calculate attrition rates, and functional survival time. Yearly bio-efficacy testing was done on randomly selected LLINs. An excel tool developed by vector works project was used to calculate the median functional survival time of the LLINs. Predictors of functional survival were identified by fitting binary and multivariate cox proportional hazards model. A total of 3,396 LLINs were included in the analysis. A total of 3,396 LLINs were included in the analysis. By the end of 36 months, the proportion of LLINs functionally surviving was 12.9% [95% confidence interval (CI) 10.5, 15.6], the rates of attrition due to physical damage and repurposing were 48.8% [95% confidence interval (CI) 45.0, 52.6] and 13.8% [95% confidence interval (CI) 11.6, 14.6], respectively. The estimated median functional survival time was 19 months (95%CI 17, 21). Factors associated with shorter functional survival time include being in a low malaria transmission setting [Adjusted Hazards Ratio (AHR) (95%CI) 1.77 (1.22, 2.55)], rural locations [AHR (95%CI) 1.83 (1.17, 2.84)], and in a room where cooking occurs [AHR (95%CI) 1.28 (1.05, 1.55)]. Bioassay tests revealed that 95.3% (95%CI 86.4, 98.5) of the LLINs met the WHO criteria of bio-efficacy after 24 months of distribution. The LLIN survival time was shorter than the expected three years due to high attrition rates and rapid loss of physical integrity. National malaria programmes may consider, procuring more durable LLINs, educating communities on how to prevent damage of LLINs, and revising the current three-year LLIN distribution schedule to ensure sufficient protection is provided by LLINs against malaria transmission. While this paper contributes to the understanding of determinants impacting functional survival, further research is needed to understand factors for the rapid attrition rates and loss of physical integrity of LLINs in field settings.

Sections du résumé

BACKGROUND BACKGROUND
The functional survival time of long-lasting insecticidal nets (LLINs), which varies across different field contexts, is critical for the successful prevention of malaria transmission. However, there is limited data on LLIN durability in field settings in Ethiopia.
METHODS METHODS
A three-year longitudinal study was conducted to monitor attrition, physical integrity, and bio-efficacy and residual chemical concentration of LLINs in four regions in Ethiopia. World Health Organization (WHO) guidelines were used to determine sample size, measure physical integrity, and calculate attrition rates, and functional survival time. Yearly bio-efficacy testing was done on randomly selected LLINs. An excel tool developed by vector works project was used to calculate the median functional survival time of the LLINs. Predictors of functional survival were identified by fitting binary and multivariate cox proportional hazards model.
RESULTS RESULTS
A total of 3,396 LLINs were included in the analysis. A total of 3,396 LLINs were included in the analysis. By the end of 36 months, the proportion of LLINs functionally surviving was 12.9% [95% confidence interval (CI) 10.5, 15.6], the rates of attrition due to physical damage and repurposing were 48.8% [95% confidence interval (CI) 45.0, 52.6] and 13.8% [95% confidence interval (CI) 11.6, 14.6], respectively. The estimated median functional survival time was 19 months (95%CI 17, 21). Factors associated with shorter functional survival time include being in a low malaria transmission setting [Adjusted Hazards Ratio (AHR) (95%CI) 1.77 (1.22, 2.55)], rural locations [AHR (95%CI) 1.83 (1.17, 2.84)], and in a room where cooking occurs [AHR (95%CI) 1.28 (1.05, 1.55)]. Bioassay tests revealed that 95.3% (95%CI 86.4, 98.5) of the LLINs met the WHO criteria of bio-efficacy after 24 months of distribution.
CONCLUSION CONCLUSIONS
The LLIN survival time was shorter than the expected three years due to high attrition rates and rapid loss of physical integrity. National malaria programmes may consider, procuring more durable LLINs, educating communities on how to prevent damage of LLINs, and revising the current three-year LLIN distribution schedule to ensure sufficient protection is provided by LLINs against malaria transmission. While this paper contributes to the understanding of determinants impacting functional survival, further research is needed to understand factors for the rapid attrition rates and loss of physical integrity of LLINs in field settings.

Identifiants

pubmed: 36967389
doi: 10.1186/s12936-023-04540-3
pii: 10.1186/s12936-023-04540-3
pmc: PMC10041722
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109

Subventions

Organisme : FIC NIH HHS
ID : D43 TW011386
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

PLoS Med. 2011 Apr;8(4):e1001019
pubmed: 21532734
BMC Infect Dis. 2014 Feb 08;14:69
pubmed: 24507444
Am J Trop Med Hyg. 2015 Feb;92(2):286-93
pubmed: 25404079
Infect Dis Poverty. 2018 Nov 05;7(1):103
pubmed: 30392470
Parasit Vectors. 2017 Nov 13;10(1):564
pubmed: 29132421
Malar J. 2017 Oct 2;16(1):396
pubmed: 28969636
Malar J. 2013 Jul 15;12:242
pubmed: 23855778
Malar J. 2011 Apr 14;10:87
pubmed: 21492423
Malar J. 2011 Oct 13;10:299
pubmed: 21992483
Malar J. 2015 Mar 24;14:123
pubmed: 25890233
PLoS One. 2015 Jun 05;10(6):e0128499
pubmed: 26047494
Malar J. 2018 Jun 20;17(1):239
pubmed: 29925371
Parasit Vectors. 2020 Jan 20;13(1):35
pubmed: 31959237
Malar J. 2020 Feb 4;19(1):58
pubmed: 32019586
Malar J. 2016 Mar 18;15:176
pubmed: 26993981
Malar J. 2016 Feb 19;15:106
pubmed: 26891696
Malar J. 2014 Nov 27;13:464
pubmed: 25430956
Malar J. 2012 Jun 07;11:183
pubmed: 22676648
Med Vet Entomol. 2004 Jun;18(2):153-60
pubmed: 15189240
Parasit Vectors. 2014 Jan 04;7:6
pubmed: 24387635
Am J Trop Med Hyg. 2012 Sep;87(3):407-411
pubmed: 22802441

Auteurs

Honelgn Nahusenay Hiruy (HN)

Department of Epidemiology and Biostatistics, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.

Seth R Irish (SR)

U.S. President's Malaria Initiative, Entomology Branch, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.

Semira Abdelmenan (S)

Department of Epidemiology and Biostatistics, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia. semiraabdelmenan@addiscontinental.edu.et.

Yonas Wuletaw (Y)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Ayele Zewde (A)

Department of Global Health and Policy, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.

Adugna Woyessa (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Mebrahtom Haile (M)

Ethiopia Federal Ministry of Health, National Malaria Elimination Program, Addis Ababa, Ethiopia.

Sheleme Chibsa (S)

U.S. President's Malaria Initiative, USA Agency for International Development, Addis Ababa, Ethiopia.

Lena Lorenz (L)

U.S. President's Malaria Initiative, USA Agency for International Development, Addis Ababa, Ethiopia.
Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Ifakara Health Institute, Dar-Es-Salaam, Tanzania.
College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland.

Alemayehu Worku (A)

Department of Epidemiology and Biostatistics, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.

Josh Yukich (J)

Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.

Yemane Berhane (Y)

Department of Epidemiology and Biostatistics, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.

Joseph Keating (J)

Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH